- Home
- DORM vs AXSM Comparison
DORM vs AXSM Comparison
Compare DORM & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DORM
- AXSM
- Stock Information
- Founded
- DORM 1978
- AXSM 2012
- Country
- DORM United States
- AXSM United States
- Employees
- DORM N/A
- AXSM N/A
- Industry
- DORM Auto Parts:O.E.M.
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- DORM Consumer Discretionary
- AXSM Health Care
- Exchange
- DORM Nasdaq
- AXSM Nasdaq
- Market Cap
- DORM 4.9B
- AXSM 5.9B
- IPO Year
- DORM 1991
- AXSM 2015
- Fundamental
- Price
- DORM $147.61
- AXSM $119.94
- Analyst Decision
- DORM Strong Buy
- AXSM Strong Buy
- Analyst Count
- DORM 4
- AXSM 19
- Target Price
- DORM $180.50
- AXSM $174.26
- AVG Volume (30 Days)
- DORM 140.3K
- AXSM 498.1K
- Earning Date
- DORM 10-30-2025
- AXSM 11-11-2025
- Dividend Yield
- DORM N/A
- AXSM N/A
- EPS Growth
- DORM 34.51
- AXSM N/A
- EPS
- DORM 7.35
- AXSM N/A
- Revenue
- DORM $2,086,196,000.00
- AXSM $495,033,000.00
- Revenue This Year
- DORM $10.24
- AXSM $63.62
- Revenue Next Year
- DORM $5.33
- AXSM $55.72
- P/E Ratio
- DORM $20.08
- AXSM N/A
- Revenue Growth
- DORM 6.76
- AXSM 69.83
- 52 Week Low
- DORM $106.95
- AXSM $75.56
- 52 Week High
- DORM $166.89
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- DORM 39.82
- AXSM 53.71
- Support Level
- DORM $153.27
- AXSM $117.60
- Resistance Level
- DORM $158.17
- AXSM $122.14
- Average True Range (ATR)
- DORM 4.15
- AXSM 3.31
- MACD
- DORM -1.17
- AXSM -0.08
- Stochastic Oscillator
- DORM 3.71
- AXSM 57.02
About DORM Dorman Products Inc.
Dorman Products Inc is a supplier of original equipment parts for automobiles. It offers automotive and heavy-duty replacement parts, automotive hardware, brake parts, and fasteners for the automotive and heavy-duty aftermarket. The products are sold under the Dorman brand and its sub-brands OE Solutions, Help!, Conduct-Tite, Super ATV, etc., through aftermarket retailers, warehouse distributors, specialty markets, and salvage yards. The company operates through three business segments, which include Light Duty, Heavy Duty, and Specialty Vehicle. A majority of its revenue is generated from the Light Duty segment, which designs and markets replacement parts and fasteners mainly for passenger cars and light trucks. Geographically, it derives key revenue from the United States.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.